Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,721,799
+$2,721,799 QoQ
Shares Held
5,069
Ownership
0.022%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#147
of 411 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Mar 31, 2026CallValue
$1,046,940
CallShares
2,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. MDGL ranks #16 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in MDGL
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,721,799 | 5,069 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,046,940 | 2,000 | Call | Sole | 2026-05-15 | |
| 2025-09-30 | $664,598 | 1,449 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $917,320 | 2,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $1,074,674 | 3,551 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,271,227 | 9,876 | Shares | Sole | 2025-05-15 | |
| 2023-06-30 | $3,118,500 | 13,500 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $2,900,094 | 11,971 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $1,308,204 | 5,400 | Put | Sole | 2023-05-15 | |
| 2022-09-30 | $1,754,730 | 27,000 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $1,319,297 | 20,300 | Put | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||